KAREN HENNINGTON: Open Payments
NPI 1174191647 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 25 payments from 11 companies in 2025. Trend: 2023 $568 · 2024 $322 · 2025 $737
Food & beverage: $734Education: $3
| Company | Payments | Amount |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 3 | $162 |
| AKEBIA THERAPEUTICS INC | 1 | $125 |
| Travere Therapeutics, Inc. | 5 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Amgen Inc. | 1 | $31 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
Products named: LUPKYNIS, Vafseo, JYNARQUE, Fabhalta, JARDIANCE, Kerendia, FARXIGA, TAVNEOS.
Industry payments across GA — which companies pay providers there.
